Mira A. Kohorst, M.D.

Mira Ann Kohorst, M.D., is director of the Pediatric Blood and Marrow Transplantation Program in the Department of Pediatric and Adolescent Medicine at Mayo Clinic in Rochester, Minnesota. She also serves as a consultant in the Division of Pediatric Hematology/Oncology and as medical director for Pediatric Patient and Family Experience and Child Life for Mayo Clinic Children’s. Dr. Kohorst specializes in the care of children and adolescents with cancer and complex blood disorders, offering advanced therapies such as immunotherapy, bone marrow transplant, CAR T-cell therapy, and gene therapy. Her practice is dedicated to helping young patients and families navigate diagnosis, treatment, and recovery with the highest level of compassion and multidisciplinary support.

Areas of expertise

Dr. Kohorst provides advanced, individualized care for children and adolescents with cancer, blood diseases, and conditions requiring cellular or gene-based therapy.

• Bone marrow transplant: Autologous and allogeneic transplantation for hematologic malignancies and nonmalignant conditions
• CAR T-cell and gene therapy: Novel immune and genetic approaches to treat refractory or high-risk disorders
• Pediatric leukemia and lymphoma: Comprehensive management using chemotherapy, targeted immunotherapies, and cellular therapies

Research and expertise

Dr. Kohorst is board-certified in pediatrics, pediatric hematology/oncology, and clinical pharmacology. She completed medical school, residency, and fellowship training at Mayo Clinic, followed by a specialized fellowship in pediatric stem cell transplantation and cellular therapy at MD Anderson Cancer Center. Her research interests include optimizing transplant and cellular therapy protocols, pediatric clinical pharmacology, and improving therapeutic safety and efficacy for children undergoing advanced oncology treatments.

As a clinician, educator, and researcher, Dr. Kohorst is committed to integrating innovation and empathy in pediatric cancer care — supporting both scientific discovery and the well-being of her patients and their families.